Ron Muhlenkamp's Firm Starts 3 Positions in 3rd Quarter

In this article:

Muhlenkamp & Co. Inc., the firm founded by Ronald Muhlenkamp (Trades, Portfolio), disclosed this week that its three new positions for the third quarter were in Berkshire Hathaway Inc. (NYSE:BRK.B), Lockheed Martin Corp. (NYSE:LMT) and CVS Health Corp. (NYSE:CVS).


The firm seeks long-term capital appreciation through stocks that have solid balance sheets and a return on equity of at least 15%. Muhlenkamp discussed in his shareholder letter several key market drivers during the second half of the year, including the U.S. - China trade war and the 2020 presidential elections. Given the potential for market volatility, Muhlenkamp reiterated his patient, defensive investing approach. The firm continues to evaluate its holdings "on an individual basis," selling the overvalued stocks and buying the undervalued stocks. Additionally, Muhlenkamp seeks to avoid cyclical stocks, those that are "particularly sensitive to the economic cycle."

dcb04fb9f102678008792492d045562a.png
dcb04fb9f102678008792492d045562a.png

As of quarter-end, Muhlenkamp & Co's $205-million equity portfolio contains 34 stocks with a turnover ratio of 12%. The portfolio's top-three sectors in terms of weight are technology, health care and industrials.

5bacc3f1e159fbfb7e7f512af5c5e97f.png
5bacc3f1e159fbfb7e7f512af5c5e97f.png

Berkshire Hathaway

Muhlenkamp's firm purchased 36,322 Class B shares of Berkshire Hathaway, giving the position 3.68% weight in the equity portfolio. Shares averaged $206.13 during the quarter.

40d11b9436de18064764149ac26902e7.png
40d11b9436de18064764149ac26902e7.png

Long-time Berkshire investor David Rolfe (Trades, Portfolio) closed his position in Warren Buffett (Trades, Portfolio)'s conglomerate, saying in Wedgewood's third-quarter shareholder letter that Berkshire's $125 billion cash pile hindered Wedgewood's goal of achieving a 10% growth rate.

abb2dc50f08c95a24e44538da352e5b5.png
abb2dc50f08c95a24e44538da352e5b5.png

On Friday, Tech Data Corp. (NASDAQ:TECD) announced it has agreed to allow Tiger Midco, LLC, an affiliate of funds managed by private-equity company Apollo Global Management Inc. (NYSE:APO), to acquire all shares of the Clearwater, Florida-based computer hardware company in a transaction valued at approximately $6 billion.

af4d7128c18712c9954866664ede5287.png
af4d7128c18712c9954866664ede5287.png

CNBC columnist Becky Quick said Berkshire, whose cash pile soared over $128 billion according to its latest quarterly report, announced an offer of $140 per share for Tech Data, a transaction valued at approximately $5 billion excluding debt. Apollo then sweetened its offer to $145 per share; Tech Data agreed to the revised offer while Buffett's conglomerate backed away.

According to stock picks statistics, Berkshire's new positions for the quarter are Occidental Petroleum Corp. (NYSE:OXY) and RH (NYSE:RH).

Lockheed Martin

The firm purchased 18,888 shares of Lockheed Martin, giving the position 3.59% weight in the equity portfolio. Shares averaged $376.12 during the quarter.

eec24f71be86011265268fafb2f2f7fb.png
eec24f71be86011265268fafb2f2f7fb.png

The Bethesda, Maryland-based company operates defense contracts like the F-35. GuruFocus ranks Lockheed Martin's profitability 9 out of 10 on several positive investing signs, which include a perfect Piotroski F-score of 9 and operating margins that have increased approximately 4.40% per year on average over the past five years and are outperforming 80.67% of global competitors.

b25be921da5eb4f1599ce1e9429c25ac.png
b25be921da5eb4f1599ce1e9429c25ac.png

Other gurus with holdings in Lockheed Martin include Joel Greenblatt (Trades, Portfolio) and Ken Heebner (Trades, Portfolio).

4f0b1f3b7d4b086f59a5b3fd34ea4376.png
4f0b1f3b7d4b086f59a5b3fd34ea4376.png

CVS

The firm purchased 70,035 shares of CVS, giving the position 2.15% weight in the equity portfolio. Shares averaged $59.22 during the quarter.

8a63abb5aaf3f514d5f92c7b986496e2.png
8a63abb5aaf3f514d5f92c7b986496e2.png

The Woonsocket, Rhode Island-based company operates a retail pharmacy chain that processes over 1.3 million prescriptions per year. GuruFocus ranks CVS's profitability 8 out of 10 primarily on the heels of the company's 4.5-star business predictability rank even though operating margins are near a 10-year low of 5% and underperforming 52.94% of global competitors. Warning signs include declining profit margins and higher asset growth compared to revenue growth.

8c829b2faef8b0b4d22a374b94912af6.png
8c829b2faef8b0b4d22a374b94912af6.png

Disclosure: No positions.

Read more here:

  • Top 5 Holdings of Al Gore's Generation Investment Management

  • Top 5 Buys of Steve Mandel's Lone Pine

  • Louis Moore Bacon's Top 6 Buys in the 3rd Quarter



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.


Advertisement